{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T17:32:28Z","timestamp":1790616748639,"version":"4.1.0"},"reference-count":55,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2015,3,1]],"date-time":"2015-03-01T00:00:00Z","timestamp":1425168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,3,1]],"date-time":"2015-03-01T00:00:00Z","timestamp":1425168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Chest Medicine"],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.1016\/j.ccm.2014.10.005","type":"journal-article","created":{"date-parts":[[2014,11,6]],"date-time":"2014-11-06T14:49:02Z","timestamp":1415285342000},"page":"79-90","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":78,"title":["Treatment of Slowly Growing Mycobacteria"],"prefix":"10.1016","volume":"36","author":[{"given":"Julie V.","family":"Philley","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David E.","family":"Griffith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ccm.2014.10.005_bib1","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.ccm.2012.02.002","article-title":"Bronchiectasis and nontuberculous mycobacterial disease","volume":"33","author":"Griffith","year":"2012","journal-title":"Clin Chest Med"},{"key":"10.1016\/j.ccm.2014.10.005_bib2","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1164\/rccm.200805-686OC","article-title":"Pulmonary nontuberculous mycobacterial disease: prospective study of a distinct preexisting syndrome","volume":"178","author":"Kim","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ccm.2014.10.005_bib3","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1164\/rccm.201206-1035OC","article-title":"Patients with nontuberculous mycobacterial lung disease exhibit unique body and immune phenotypes","volume":"187","author":"Kartalija","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ccm.2014.10.005_bib4","first-page":"808","article-title":"Pulmonary Mycobacterium avium complex infection associated with the IVS8-T5 allele of the CFTR gene","volume":"11","author":"Mai","year":"2007","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.ccm.2014.10.005_bib5","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1164\/rccm.200909-1434OC","article-title":"Cystic fibrosis transmembrane conductance regulator channel dysfunction in non-cystic fibrosis bronchiectasis","volume":"181","author":"Bienvenu","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"issue":"7","key":"10.1016\/j.ccm.2014.10.005_bib6","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1513\/AnnalsATS.201404-184OC","article-title":"Environmental risks for nontuberculous mycobacteria: individual exposures and climatic factors in the cystic fibrosis population","volume":"11","author":"Prevots","year":"2014","journal-title":"Ann Am Thorac Soc"},{"issue":"5","key":"10.1016\/j.ccm.2014.10.005_bib7","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1164\/rccm.201405-0884OC","article-title":"Nontuberculous mycobacteria among cystic fibrosis patients in the United States: screening practices and environmental risk","volume":"190","author":"Adjemian","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ccm.2014.10.005_bib8","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1586\/14787210.2013.830413","article-title":"Drug treatment of pulmonary nontuberculous mycobacterial disease in HIV-negative patients: the evidence","volume":"11","author":"van Ingen","year":"2013","journal-title":"Expert Rev Anti Infect Ther"},{"key":"10.1016\/j.ccm.2014.10.005_bib9","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.carj.2013.05.006","article-title":"Comparison of the spectrum of radiologic and clinical manifestations of pulmonary disease caused by Mycobacterium avium complex and Mycobacterium xenopi","volume":"65","author":"Carrillo","year":"2014","journal-title":"Can Assoc Radiol J"},{"key":"10.1016\/j.ccm.2014.10.005_bib10","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1164\/rccm.201107-1203OC","article-title":"Prognostic factors of 634 HIV-negative patients with Mycobacterium avium complex lung disease","volume":"185","author":"Hayashi","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"10.1016\/j.ccm.2014.10.005_bib11","doi-asserted-by":"crossref","first-page":"408","DOI":"10.5588\/ijtld.11.0148","article-title":"Predictors of 5-year mortality in pulmonary Mycobacterium avium-intracellulare complex disease","volume":"16","author":"Ito","year":"2012","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.ccm.2014.10.005_bib12","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/s00408-011-9321-4","article-title":"Clinical characteristics and prognosis of nontuberculous mycobacterial lung disease with different radiographic patterns","volume":"189","author":"Shu","year":"2011","journal-title":"Lung"},{"key":"10.1016\/j.ccm.2014.10.005_bib13","doi-asserted-by":"crossref","first-page":"660","DOI":"10.5588\/ijtld.11.0534","article-title":"Long-term radiographic outcome of nodular bronchiectatic Mycobacterium avium complex pulmonary disease","volume":"16","author":"Kitada","year":"2012","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.ccm.2014.10.005_bib14","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1164\/rccm.200604-571ST","article-title":"An official ATS\/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases","volume":"175","author":"Griffith","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ccm.2014.10.005_bib15","series-title":"Susceptibility testing of mycobacteria, nocardiae, and other aerobic actinomycetes; approved standard","author":"Woods","year":"2003"},{"key":"10.1016\/j.ccm.2014.10.005_bib16","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s10156-006-0457-8","article-title":"Relationship between clinical efficacy of treatment of pulmonary Mycobacterium avium complex disease and drug-sensitivity testing of Mycobacterium avium complex isolates","volume":"12","author":"Kobashi","year":"2006","journal-title":"J\u00a0Infect Chemother"},{"key":"10.1016\/j.ccm.2014.10.005_bib17","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1164\/ajrccm.153.6.8665032","article-title":"Clarithromycin regimens for pulmonary Mycobacterium avium complex. The first 50 patients","volume":"153","author":"Wallace","year":"1996","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ccm.2014.10.005_bib18","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1093\/clinids\/23.5.983","article-title":"Azithromycin activity against Mycobacterium avium complex lung disease in patients who were not infected with human immunodeficiency virus","volume":"23","author":"Griffith","year":"1996","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ccm.2014.10.005_bib19","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1164\/ajrccm.160.3.9811086","article-title":"Effect of clarithromycin regimen for Mycobacterium avium complex pulmonary disease","volume":"160","author":"Tanaka","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ccm.2014.10.005_bib20","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.drup.2012.04.001","article-title":"Resistance mechanisms and drug susceptibility testing of nontuberculous mycobacteria","volume":"15","author":"van Ingen","year":"2012","journal-title":"Drug Resist Updat"},{"key":"10.1016\/j.ccm.2014.10.005_bib21","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1164\/rccm.201204-0682OC","article-title":"The pharmacokinetics and pharmacodynamics of pulmonary Mycobacterium avium complex disease treatment","volume":"186","author":"van Ingen","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ccm.2014.10.005_bib22","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1016\/S0140-6736(10)60492-8","article-title":"Early treatment outcomes and HIV status of patients with extensively drug-resistant tuberculosis in South Africa: a retrospective cohort study","volume":"375","author":"Dheda","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.ccm.2014.10.005_bib23","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1513\/AnnalsATS.201304-085OC","article-title":"Lack of adherence to evidence-based treatment guidelines for nontuberculous mycobacterial lung disease","volume":"11","author":"Adjemian","year":"2014","journal-title":"Ann Am Thorac Soc"},{"key":"10.1016\/j.ccm.2014.10.005_bib24","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1513\/AnnalsATS.201305-136OC","article-title":"Opinions differ by expertise in Mycobacterium avium complex disease","volume":"11","author":"Marras","year":"2014","journal-title":"Ann Am Thorac Soc"},{"issue":"2","key":"10.1016\/j.ccm.2014.10.005_bib25","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1378\/chest.13-2538","article-title":"Macrolide\/azalide therapy for nodular\/bronchiectatic: Mycobacterium avium complex lung disease","volume":"146","author":"Wallace","year":"2014","journal-title":"Chest"},{"key":"10.1016\/j.ccm.2014.10.005_bib26","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1513\/AnnalsATS.201308-266OC","article-title":"Efficacy of clarithromycin and ethambutol for Mycobacterium avium complex pulmonary disease. A preliminary study","volume":"11","author":"Miwa","year":"2014","journal-title":"Ann Am Thorac Soc"},{"key":"10.1016\/j.ccm.2014.10.005_bib27","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1471-2466-7-2","article-title":"Aerosolized amikacin for treatment of pulmonary Mycobacterium avium infections: an observational case series","volume":"7","author":"Davis","year":"2007","journal-title":"BMC Pulm Med"},{"key":"10.1016\/j.ccm.2014.10.005_bib28","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1513\/AnnalsATS.201307-231OC","article-title":"Inhaled amikacin for treatment of refractory pulmonary nontuberculous mycobacterial disease","volume":"11","author":"Olivier","year":"2014","journal-title":"Ann Am Thorac Soc"},{"key":"10.1016\/j.ccm.2014.10.005_bib29","unstructured":"Olivier KN, Gupta R, Daley CL et\u00a0al. A controlled study of liposomal amikacin for inhalation in patients with recalcitrant nontuberculous mycobacterial lung disease. Abstract #50985, Presented at the annual meeting of the American Thoracic Society. San Diego, May 16\u201321, 2014."},{"key":"10.1016\/j.ccm.2014.10.005_bib30","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1370\/afm.1601","article-title":"Azithromycin and levofloxacin use and increased risk of cardiac arrhythmia and death","volume":"12","author":"Rao","year":"2014","journal-title":"Ann Fam Med"},{"key":"10.1016\/j.ccm.2014.10.005_bib31","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1164\/rccm.200603-450OC","article-title":"Clinical and molecular analysis of macrolide resistance in Mycobacterium avium complex lung disease","volume":"174","author":"Griffith","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ccm.2014.10.005_bib32","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1128\/AAC.02281-12","article-title":"Treatment of refractory Mycobacterium avium complex lung disease with a moxifloxacin-containing regimen","volume":"57","author":"Koh","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"issue":"10","key":"10.1016\/j.ccm.2014.10.005_bib33","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.jiac.2014.05.010","article-title":"Treatment outcomes of refractory MAC pulmonary disease treated with drugs with unclear efficacy","volume":"20","author":"Jo","year":"2014","journal-title":"J\u00a0Infect Chemother"},{"key":"10.1016\/j.ccm.2014.10.005_bib34","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1378\/chest.124.4.1482","article-title":"Treatment of Mycobacterium avium-intracellulare complex lung disease with a macrolide, ethambutol, and clofazimine","volume":"124","author":"Field","year":"2003","journal-title":"Chest"},{"key":"10.1016\/j.ccm.2014.10.005_bib35","doi-asserted-by":"crossref","first-page":"6324","DOI":"10.1128\/AAC.01505-12","article-title":"In\u00a0vitro synergy between clofazimine and amikacin in treatment of nontuberculous mycobacterial disease","volume":"56","author":"van Ingen","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ccm.2014.10.005_bib36","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/j.athoracsur.2012.01.012","article-title":"Thoracoscopic lobectomy and segmentectomy for infectious lung disease","volume":"93","author":"Mitchell","year":"2012","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.ccm.2014.10.005_bib37","first-page":"671","article-title":"Lady Windermere revisited: treatment with thoracoscopic lobectomy\/segmentectomy for right middle lobe and lingular bronchiectasis associated with non-tuberculous mycobacterial disease","volume":"40","author":"Yu","year":"2011","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.ccm.2014.10.005_bib38","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1086\/378742","article-title":"Thrice-weekly clarithromycin-containing regimen for treatment of Mycobacterium kansasii lung disease: results of a preliminary study","volume":"37","author":"Griffith","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ccm.2014.10.005_bib39","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1183\/09031936.03.00299903","article-title":"Pulmonary disease caused by M. malmoense in HIV negative patients: 5-yr follow-up of patients receiving standardised treatment","volume":"21","year":"2003","journal-title":"Eur Respir J"},{"key":"10.1016\/j.ccm.2014.10.005_bib40","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1136\/thx.2007.087999","article-title":"Clarithromycin vs ciprofloxacin as adjuncts to rifampicin and ethambutol in treating opportunist mycobacterial lung diseases and an assessment of Mycobacterium vaccae immunotherapy","volume":"63","author":"Jenkins","year":"2008","journal-title":"Thorax"},{"key":"10.1016\/j.ccm.2014.10.005_bib41","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1183\/09031936.00039009","article-title":"Clinical relevance of Mycobacterium malmoense isolation in The Netherlands","volume":"34","author":"Hoefsloot","year":"2009","journal-title":"Eur Respir J"},{"key":"10.1016\/j.ccm.2014.10.005_bib42","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1136\/thorax.56.3.167","article-title":"First randomised trial of treatments for pulmonary disease caused by M avium intracellulare, M malmoense, and M xenopi in HIV negative patients: rifampicin, ethambutol and isoniazid versus rifampicin and ethambutol","volume":"56","author":"Research Committee of the British Thoracic Society","year":"2001","journal-title":"Thorax"},{"key":"10.1016\/j.ccm.2014.10.005_bib43","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1136\/thx.2008.096842","article-title":"Mycobacterium xenopi pulmonary infections: a multicentric retrospective study of 136 cases in north-east France","volume":"64","author":"Andrejak","year":"2009","journal-title":"Thorax"},{"key":"10.1016\/j.ccm.2014.10.005_bib44","doi-asserted-by":"crossref","first-page":"385","DOI":"10.3201\/eid1403.061393","article-title":"Mycobacterium xenopi clinical relevance and determinants, the Netherlands","volume":"14","author":"van Ingen","year":"2008","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.ccm.2014.10.005_bib45","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1093\/jac\/dks421","article-title":"Improving existing tools for Mycobacterium xenopi treatment: assessment of drug combinations and characterization of mouse models of infection and chemotherapy","volume":"68","author":"Andrejak","year":"2013","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.ccm.2014.10.005_bib46","doi-asserted-by":"crossref","first-page":"169","DOI":"10.3109\/00365548.2013.861607","article-title":"Clinical significance of Mycobacterium szulgai isolates from respiratory specimens","volume":"46","author":"Yoo","year":"2014","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.ccm.2014.10.005_bib47","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1086\/529443","article-title":"Clinical relevance of Mycobacterium szulgai in The Netherlands","volume":"46","author":"van Ingen","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ccm.2014.10.005_bib48","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1183\/09031936.00076107","article-title":"Clinical relevance of Mycobacterium simiae in pulmonary samples","volume":"31","author":"van Ingen","year":"2008","journal-title":"Eur Respir J"},{"key":"10.1016\/j.ccm.2014.10.005_bib49","doi-asserted-by":"crossref","first-page":"2676","DOI":"10.1128\/AAC.38.11.2676","article-title":"Activities of clarithromycin, ofloxacin, and clarithromycin plus ethambutol against Mycobacterium simiae in murine model of disseminated infection","volume":"38","author":"Valero","year":"1994","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ccm.2014.10.005_bib50","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1164\/ajrccm.152.5.7582293","article-title":"Clinical isolates of Mycobacterium simiae in San Antonio, Texas. An 11-yr review","volume":"152","author":"Valero","year":"1995","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ccm.2014.10.005_bib51","doi-asserted-by":"crossref","first-page":"419","DOI":"10.3201\/eid1703.101510","article-title":"Nontuberculous mycobacteria from household plumbing of patients with nontuberculous mycobacteria disease","volume":"17","author":"Falkinham","year":"2011","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.ccm.2014.10.005_bib52","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1513\/AnnalsATS.201309-297OC","article-title":"Association between polyclonal and mixed mycobacterial Mycobacterium avium complex infection and environmental exposure","volume":"11","author":"Fujita","year":"2014","journal-title":"Ann Am Thorac Soc"},{"key":"10.1016\/j.ccm.2014.10.005_bib53","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1056\/NEJMoa1104623","article-title":"Azithromycin for prevention of exacerbations of COPD","volume":"365","author":"Albert","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ccm.2014.10.005_bib54","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/S0140-6736(12)60953-2","article-title":"Azithromycin for prevention of exacerbations in non-cystic fibrosis bronchiectasis (EMBRACE): a randomised, double-blind, placebo-controlled trial","volume":"380","author":"Wong","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.ccm.2014.10.005_bib55","doi-asserted-by":"crossref","first-page":"3389","DOI":"10.1128\/JCM.01612-13","article-title":"In\u00a0vitro activity of amikacin against isolates of Mycobacterium avium complex with proposed MIC breakpoints and finding of a 16S rRNA gene mutation in treated isolates","volume":"51","author":"Brown-Elliott","year":"2013","journal-title":"J\u00a0Clin Microbiol"}],"container-title":["Clinics in Chest Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272523114001087?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272523114001087?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T00:50:43Z","timestamp":1759452643000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0272523114001087"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3]]},"references-count":55,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,3]]}},"alternative-id":["S0272523114001087"],"URL":"https:\/\/doi.org\/10.1016\/j.ccm.2014.10.005","relation":{},"ISSN":["0272-5231"],"issn-type":[{"value":"0272-5231","type":"print"}],"subject":[],"published":{"date-parts":[[2015,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment of Slowly Growing Mycobacteria","name":"articletitle","label":"Article Title"},{"value":"Clinics in Chest Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ccm.2014.10.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}